Dr. Ahmad Yusuf Solaiman, MD

Dr. Yusuf Solaiman practices at Henry Ford Hospital in Detroit, Michigan, part of Henry Ford Health.

Dr. Yusuf Solaiman's NPI, 1598151284, was assigned on April 9, 2015. Dr. Yusuf Solaiman holds Michigan license 4301116943.

Dr. Yusuf Solaiman's primary practice is Henry Ford Hospital, at 2799 W Grand Blvd, Detroit, MI 48202 in Wayne County. The practice phone is (313) 916-2600.

Dr. Yusuf Solaiman's primary practice is Henry Ford Hospital in Detroit, Michigan, part of Henry Ford Health. Dr. Yusuf Solaiman is also affiliated with Henry Ford West Bloomfield Hospital. The medical group on file is Henry Ford Health. Dmand AI also links Dr. Yusuf Solaiman to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yusuf Solaiman practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Yusuf Solaiman's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Yusuf Solaiman's licenses on file in 2 states: Michigan and Texas.

CMS data shows 156 Medicare services from Dr. Yusuf Solaiman across 6 procedure codes in 2024, for 140 Medicare patients. Medicare paid $11,093 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 140 Medicare patients who saw Dr. Yusuf Solaiman in 2024. The largest group is 65 to 74, with 46 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 49% are also on Medicaid. Their average risk score is 2.48, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yusuf Solaiman's median patient age at 59, with 51% women.

In 2024, Dr. Yusuf Solaiman wrote 1,213 Medicare Part D claims for 176 patients. 82% of them were for generic drugs. CMS names the drug for 1,083 of them, across 22 drugs with 11 or more claims each, at $358,501 in total drug cost. In 2023, CMS named 1,094 claims across 21 drugs.

Dr. Yusuf Solaiman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Yusuf Solaiman as offering telehealth.

Dmand AI links 1 paper to Dr. Yusuf Solaiman in 2014. Dr. Yusuf Solaiman's most frequent co-author is Abdulrahman Morad, MD.

CMS Open Payments shows 4 general payments to Dr. Yusuf Solaiman from 4 drug and device companies from 2017 to 2023. Food and beverage make up the largest share, 100% of the total. DIXI Medical USA Corp paid the most, $729.